Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
1.4M
-
Shares change
-
+580K
-
Total reported value, excl. options
-
$161M
-
Value change
-
+$67.4M
-
Put/Call ratio
-
0.19
-
Number of buys
-
32
-
Number of sells
-
-28
-
Price
-
$115.20
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q3 2016
83 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q3 2016.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.4M shares
.
Largest 10 shareholders include ALLIANCEBERNSTEIN L.P. (598K shares), GOLDMAN SACHS GROUP INC (102K shares), UBS Group AG (80.2K shares), MORGAN STANLEY (74.4K shares), MURPHY CAPITAL MANAGEMENT INC (46.9K shares), ROYAL BANK OF CANADA (39.6K shares), BANQUE PICTET & CIE SA (33.5K shares), Cambridge Investment Research Advisors, Inc. (28.9K shares), Timber Hill LLC (27.4K shares), and Strategic Financial Services, Inc, (27.2K shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.